BIOMARKER:

MDM2 amplification

Entrez ID:

Related biomarkers:

‹

›

MDM2 amplification MDM2 amplification	Liposarcoma Liposarcoma	APG-115 Sensitive: C2 – Inclusion Criteria
MDM2 amplification MDM2 amplification	Solid Tumor Solid Tumor	RAIN-32 Sensitive: C2 – Inclusion Criteria
MDM2 amplification MDM2 amplification	Liposarcoma Liposarcoma	RAIN-32 Sensitive: C2 – Inclusion Criteria
MDM2 amplification MDM2 amplification	Mucosal Melanoma Mucosal Melanoma	ipilimumab Resistant: C3 – Early Trials
MDM2 amplification MDM2 amplification	Mucosal Melanoma Mucosal Melanoma	nivolumab + ipilimumab Resistant: C3 – Early Trials
MDM2 amplification MDM2 amplification	Mucosal Melanoma Mucosal Melanoma	nivolumab Resistant: C3 – Early Trials
MDM2 amplification MDM2 amplification	Mucosal Melanoma Mucosal Melanoma	pembrolizumab Resistant: C3 – Early Trials
MDM2 amplification MDM2 amplification	Gastric Adenocarcinoma Gastric Adenocarcinoma	Immunotherapy Resistant: C3 – Early Trials
MDM2 amplification MDM2 amplification	Liposarcoma Liposarcoma	BI 907828 Sensitive: C3 – Early Trials
MDM2 amplification MDM2 amplification	Triple Negative Breast Cancer Triple Negative Breast Cancer	pembrolizumab Resistant: C4 – Case Studies